SCHEMBL15712705

SCHEMBL15712705

Cn1c(=O)n(Cc2ccccc2)c2ccc(Nc3ccc(Cl)cc3C(=O)O)cc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPD P32754 2/20 0.46
MPO P05164 1/20 0.45
LMNA P02545 4/20 0.45
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
POLB P06746 2/20 0.45
MAPT P10636 1/20 0.45
DHODH Q02127 1/20 0.44
PARG Q86W56 2/20 0.44
CA9 Q16790 2/20 0.44
HPGD P15428 3/20 0.44
ALDH1A1 P00352 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KDM4E B2RXH2 2/20 0.44
THRB P10828 1/20 0.44
AKR1C3 P42330 2/20 0.43
AKR1C2 P52895 2/20 0.43
GFER P55789 1/20 0.43
CA2 P00918 1/20 0.42
MMP13 P45452 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15712550 0.91 PARG (0.44) HPDLMNAKMT2AMEN1POLB
SCHEMBL15712614 0.80 MPO (0.46) MPOLMNAKMT2AMEN1POLB
SCHEMBL15712876 0.80 PGR (0.54) MPOLMNAKMT2AMEN1POLB
SCHEMBL15712546 0.80 MAPT (0.53) MPOKMT2AMEN1POLBMAPT
SCHEMBL15712717 0.80 KDM4E (0.48) MPOLMNAKMT2AMEN1POLB
SCHEMBL15712349 0.78 DHODH (0.50) MPOLMNAKMT2AMEN1POLB
SCHEMBL15712322 0.78 MPO (0.45) MPOLMNAKMT2AMEN1POLB
SCHEMBL15712611 0.77 CCR2 (0.49) MPOLMNAKMT2AMEN1POLB
SCHEMBL15712502 0.76 MPO (0.47) MPOLMNAKMT2AMEN1POLB
SCHEMBL15712503 0.76 ERBB2 (0.49) MPOLMNAKMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2915804-B1 NOVEL AMINE DERIVATIVE OR SALT THEREOF AS TNF ALPHA INHIBITORS FUJIFILM TOYAMA CHEMICAL CO LTD (JP) 2019-03-27 EP disclosed
US-9624215-B2 Amine derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2017-04-18 US disclosed
US-9624215-B2 Amine derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2017-04-18 US disclosed
US-20150299189-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2015-10-22 US disclosed
US-20150299189-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2015-10-22 US disclosed
WO-2014069510-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF 富山化学工業株式会社 (JP) 2014-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150299189-A1 NOVEL AMINE DERIVATIVE OR SALT THEREOF HRH4, CLIC4, KRT18 HPD 3578/4885MPO 607/4885LMNA 3053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.